Sun Weihua, Wang Yi, Wu Mengyuan, Wu Hongjiang, Peng Xiaomin, Shi Yingyan, Xiao Feifan, Wu Bingbing, Zhou Wenhao, Lu Wei
Pediatric Research Institute, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Department of Neurology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Transl Pediatr. 2023 May 30;12(5):927-937. doi: 10.21037/tp-23-164. Epub 2023 May 11.
This study sought to analyze the clinical characteristics, biochemical metabolic indications, treatment results, and genetic spectrum of cerebral creatine deficiency syndrome (CCDS), estimate the prevalence of CCDS in Chinese children and provide a reference to guide clinical practice.
We performed a retrospective cohort study of 3,568 children with developmental delay at Children's Hospital of Fudan University over a 6-year period (January 2017-December 2022). Metabolites in the blood/urine were detected by liquid chromatography-tandem mass spectrometry (LC-MS/MS), and genetic testing was performed by next-generation sequencing (NGS). The patients with suspected CCDS were ultimately diagnosed by magnetic resonance spectroscopy (MRS). The patients were then treated and followed up. All the reported cases of CCDS, their gene mutations, and treatment results in China were summarized.
Ultimately, 14 patients were diagnosed with CCDS. The age of onset was between 1-2 years. All the patients had developmental delay, 9 had epilepsy, and 8 had movement or behavioral disorders. A total of 17 genetic variants were identified, including 6 novel variants. c.403G>A, c.491dupG of the guanidinoacetate methyltransferase () gene had a relatively high frequency. After treatment, patients with GAMT deficiency showed obvious improvements, and brain creatine (Cr) levels recovered to 50-80% of normal, 1 patient achieved normal neurodevelopment, and 3 patients became epilepsy free; however, 6 male patients with X-linked creatine transporter gene () variants received Cr for 3-6 months with no effect, and 2 patients received combined therapy with few improvements.
The prevalence of CCDS is ~0.39% in Chinese children with developmental delay. A low-protein diet, Cr and, ornithine were useful for patients with deficiency. Male patients with deficiency showed only limited improvement on combined therapy.
本研究旨在分析脑肌酸缺乏综合征(CCDS)的临床特征、生化代谢指标、治疗效果及基因谱,评估中国儿童CCDS的患病率,为临床实践提供指导参考。
我们对复旦大学附属儿科医院6年间(2017年1月至2022年12月)3568例发育迟缓儿童进行了回顾性队列研究。采用液相色谱 - 串联质谱法(LC-MS/MS)检测血液/尿液中的代谢物,通过二代测序(NGS)进行基因检测。疑似CCDS患者最终通过磁共振波谱(MRS)确诊。随后对患者进行治疗及随访。总结了中国所有报道的CCDS病例、基因突变及治疗结果。
最终,14例患者被诊断为CCDS。发病年龄在1 - 2岁之间。所有患者均有发育迟缓,9例有癫痫,8例有运动或行为障碍。共鉴定出17种基因变异,其中包括6种新变异。胍基乙酸甲基转移酶(GAMT)基因的c.403G>A、c.491dupG变异频率相对较高。治疗后,GAMT缺乏症患者有明显改善,脑肌酸(Cr)水平恢复至正常的50 - 80%,1例患者神经发育正常,3例患者癫痫发作停止;然而,6例携带X连锁肌酸转运蛋白基因(SLC6A8)变异的男性患者接受Cr治疗3 - 6个月无效,2例患者接受联合治疗改善甚微。
中国发育迟缓儿童中CCDS的患病率约为0.39%。低蛋白饮食、Cr及鸟氨酸对GAMT缺乏症患者有效。SLC6A8缺乏症男性患者接受联合治疗改善有限。